Mitchell Sinkler & Starr’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-811	Closed	-$330K	–	230
2023 Q4	$330K	Buy	+811	New	+$330K	0.06%	152